Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

CYCN Cyclerion Therapeutics Inc

2,65

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:00:26

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Cyclerion Therapeutics Charts.

Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Cyclerion Therapeutics Charts.

News Cyclerion Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 11 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 4 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Cyclerion Appoints Regina Graul, Ph.D., as President
Montag 4 Dezember 2023 (6 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 1 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
Freitag 1 Dezember 2023 (6 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 24 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 November 2023 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 23 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
Montag 31 Juli 2023 (10 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 28 Juli 2023 (10 Monate vor) • Edgar (US Regulatory)

Weitere Cyclerion Therapeutics Inc News-Artikel

Stand.chart.8q%

NLBNPIT1WNO9 20240920 25

U S Steel CP10Squids

Orion Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen